FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201217612> ?p ?o ?g. }

• W3201217612 abstract "Abstract Background To accelerate progress toward the UNAIDS 90-90-90 targets, US Centers for Disease Control and Prevention Nigeria country office (CDC Nigeria) initiated an Antiretroviral Treatment (ART) Surge in 2019 to identify and link 340,000 people living with HIV/AIDS (PLHIV) to ART. Coronavirus disease 2019 (COVID-19) threatened to interrupt ART Surge progress following the detection of the first case in Nigeria in February 2020. To overcome this disruption, CDC Nigeria designed and implemented adapted ART Surge strategies during February–September 2020. Methods Adapted ART Surge strategies focused on continuing expansion of HIV services while mitigating COVID-19 transmission. Key strategies included an intensified focus on community-based, rather than facility-based, HIV case-finding; immediate initiation of newly-diagnosed PLHIV on 3-month ART starter packs (first ART dispense of 3 months of ART); expansion of ART distribution through community refill sites; and broadened access to multi-month dispensing (MMD) (3–6 months ART) among PLHIV established in care. State-level weekly data reporting through an Excel-based dashboard and individual PLHIV-level data from the Nigeria National Data Repository facilitated program monitoring. Results During February–September 2020, the reported number of PLHIV initiating ART per month increased from 11,407 to 25,560, with the proportion found in the community increasing from 59 to 75%. The percentage of newly-identified PLHIV initiating ART with a 3-month ART starter pack increased from 60 to 98%. The percentage of on-time ART refill pick-ups increased from 89 to 100%. The percentage of PLHIV established in care receiving at least 3-month MMD increased from 77 to 93%. Among PLHIV initiating ART, 6-month retention increased from 74 to 92%. Conclusions A rapid and flexible HIV program response, focused on reducing facility-based interactions while ensuring delivery of lifesaving ART, was critical in overcoming COVID-19-related service disruptions to expand access to HIV services in Nigeria during the first eight months of the pandemic. High retention on ART among PLHIV initiating treatment indicates immediate MMD in this population may be a sustainable practice. HIV program infrastructure can be leveraged and adapted to respond to the COVID-19 pandemic." @default.
• W3201217612 created "2021-09-27" @default.
• W3201217612 creator A5005524325 @default.
• W3201217612 creator A5006087600 @default.
• W3201217612 creator A5012159012 @default.
• W3201217612 creator A5015032524 @default.
• W3201217612 creator A5015327047 @default.
• W3201217612 creator A5015948210 @default.
• W3201217612 creator A5016429571 @default.
• W3201217612 creator A5016458721 @default.
• W3201217612 creator A5016762353 @default.
• W3201217612 creator A5017051702 @default.
• W3201217612 creator A5019580857 @default.
• W3201217612 creator A5023476225 @default.
• W3201217612 creator A5025423604 @default.
• W3201217612 creator A5033461683 @default.
• W3201217612 creator A5034669568 @default.
• W3201217612 creator A5035635097 @default.
• W3201217612 creator A5040241946 @default.
• W3201217612 creator A5040374041 @default.
• W3201217612 creator A5040400653 @default.
• W3201217612 creator A5044704389 @default.
• W3201217612 creator A5045479933 @default.
• W3201217612 creator A5045499319 @default.
• W3201217612 creator A5046094837 @default.
• W3201217612 creator A5046469990 @default.
• W3201217612 creator A5046710114 @default.
• W3201217612 creator A5047442126 @default.
• W3201217612 creator A5047494017 @default.
• W3201217612 creator A5047549189 @default.
• W3201217612 creator A5048773761 @default.
• W3201217612 creator A5048791889 @default.
• W3201217612 creator A5049936513 @default.
• W3201217612 creator A5056249501 @default.
• W3201217612 creator A5059122751 @default.
• W3201217612 creator A5067026183 @default.
• W3201217612 creator A5067333292 @default.
• W3201217612 creator A5071290223 @default.
• W3201217612 creator A5074229069 @default.
• W3201217612 creator A5074924420 @default.
• W3201217612 creator A5076247800 @default.
• W3201217612 creator A5076527618 @default.
• W3201217612 creator A5077073665 @default.
• W3201217612 creator A5080692299 @default.
• W3201217612 creator A5081763184 @default.
• W3201217612 creator A5084564522 @default.
• W3201217612 creator A5087068072 @default.
• W3201217612 creator A5090925728 @default.
• W3201217612 date "2021-09-19" @default.
• W3201217612 modified "2023-10-06" @default.
• W3201217612 title "Expanding access to HIV services during the COVID-19 pandemic—Nigeria, 2020" @default.
• W3201217612 cites W1980915866 @default.
• W3201217612 cites W2176684072 @default.
• W3201217612 cites W2792044245 @default.
• W3201217612 cites W2799404306 @default.
• W3201217612 cites W2960083702 @default.
• W3201217612 cites W3010264465 @default.
• W3201217612 cites W3019235060 @default.
• W3201217612 cites W3026374985 @default.
• W3201217612 cites W3036822331 @default.
• W3201217612 cites W3041532377 @default.
• W3201217612 cites W3043639501 @default.
• W3201217612 cites W3087006383 @default.
• W3201217612 cites W3135226103 @default.
• W3201217612 cites W3136300394 @default.
• W3201217612 cites W3137027383 @default.
• W3201217612 cites W3139032941 @default.
• W3201217612 cites W2990644906 @default.
• W3201217612 doi "https://doi.org/10.1186/s12981-021-00385-5" @default.
• W3201217612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8449993" @default.
• W3201217612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34538268" @default.
• W3201217612 hasPublicationYear "2021" @default.
• W3201217612 type Work @default.
• W3201217612 sameAs 3201217612 @default.
• W3201217612 citedByCount "20" @default.
• W3201217612 countsByYear W32012176122022 @default.
• W3201217612 countsByYear W32012176122023 @default.
• W3201217612 crossrefType "journal-article" @default.
• W3201217612 hasAuthorship W3201217612A5005524325 @default.
• W3201217612 hasAuthorship W3201217612A5006087600 @default.
• W3201217612 hasAuthorship W3201217612A5012159012 @default.
• W3201217612 hasAuthorship W3201217612A5015032524 @default.
• W3201217612 hasAuthorship W3201217612A5015327047 @default.
• W3201217612 hasAuthorship W3201217612A5015948210 @default.
• W3201217612 hasAuthorship W3201217612A5016429571 @default.
• W3201217612 hasAuthorship W3201217612A5016458721 @default.
• W3201217612 hasAuthorship W3201217612A5016762353 @default.
• W3201217612 hasAuthorship W3201217612A5017051702 @default.
• W3201217612 hasAuthorship W3201217612A5019580857 @default.
• W3201217612 hasAuthorship W3201217612A5023476225 @default.
• W3201217612 hasAuthorship W3201217612A5025423604 @default.
• W3201217612 hasAuthorship W3201217612A5033461683 @default.
• W3201217612 hasAuthorship W3201217612A5034669568 @default.
• W3201217612 hasAuthorship W3201217612A5035635097 @default.
• W3201217612 hasAuthorship W3201217612A5040241946 @default.
• W3201217612 hasAuthorship W3201217612A5040374041 @default.
• W3201217612 hasAuthorship W3201217612A5040400653 @default.
• W3201217612 hasAuthorship W3201217612A5044704389 @default.
• W3201217612 hasAuthorship W3201217612A5045479933 @default.
• W3201217612 hasAuthorship W3201217612A5045499319 @default.

• next